StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX)
StockNews.com began coverage on shares of Eagle Pharmaceuticals (NASDAQ:EGRX – Get Free Report) in a report released on Friday. The brokerage set a “hold” rating on the specialty pharmaceutical company’s stock. Eagle Pharmaceuticals Price Performance EGRX opened at $1.94 on Friday. Eagle Pharmaceuticals has a 12 month low of $1.50 and a 12 month high […]
